WHO GETS JNJ INFO HERE?
THESE NOTABLE VISITORS ;o)
Regular visitors to the JohnsonAndToxin site include these and many others...
- US SENATE
- World Health Organization
- National Health Service UK
- US Centers for Disease Control
- Department of Defense
- Department of Justice
- US Federal Reserve
- and others from the alphabet soup of government organizations around the world.
This site also regularly receives visitors from:
- offices of the DOW
- The Bank of New York Mellon Corp
- Lloyds Banking Group PLC
- Cantor Fitzgerald & Co.
- Harris Trust & Savings Bank
- BlackRock Financial Management
- The Capital Group
- RBS Securities in US
- Bank of America
- as well as other major financial institutions.
The site has the Honor of being visited by:
- Ernst & Young
- Group M (world's largest media investment group)
- Young & Rubicam PR FIRM
- Porter Novelli PR FIRM
- Grey Group PR FIRM
This site has been visited by numerous educational facilities including:
- India Institute of Management
- Quinnipiac University
- Universitaet Graz
- Baruch College
- University of North Carolina at Chapel Hill
- University of North Carolina at Greensboro
- Lancaster University
- Miami Dade College
- Marymount Manhattan College
- Loyola University
- Punjabi University
- Franciscan University
- Arizona State University
- University of Surrey London
- Loughborough University
- Southern University at New Orleans
- Amrita Vishwa Vidyapeetham University
- Northern Caribbean University
- Louisiana State University
- Hong Kong University of Science and Technology
- Oregon State University
- University of California
- Rutgers University
- Southern New Hampshire University
- Vanderbuilt University
- Macquarie University
- CRI Universite de Nantes - 2 Rue de la Houssiniere
- International Islamic University Of Malaysia
- Baylor University
- Taiwan Academic Network (TANet) Information Center
- Suffolk University
- Pittsburg State University
- Idaho State University
- University of Miami
- University of Hawaii
- University of Colorado
- Duke University
- just to name a few.
And, of course, visitors from Johnson & Johnson servers around the world, Bayer, Synthes, Merck and others.
In addition to the very interesting visitors to the web site, I have been contacted by reporters such as Steven Brill and Jane Akre, lawyers from four countries such as Michael Huttner of the US, Jacquelyn NG from DEACONS in Hong Kong, Charlie Euchner Case Writer & Project Editor Yale School of Management, a variety of whistleblowers including Scott Bartz, one of the convicted (which I cannot disclose publicly) and numerous victims. They are all using the information from the Johnson and Toxin site for their court cases and research projects asking me to do specific research in addition to what is on the site.
Johnson & Johnson Paying Outrageous Salaries Amid Massive Layoffs, Plant Closings and Facility Deterioration
Irresponsibility at J&J allows facilities to deteriorate - putting consumers at risk of harm, plants shut down by FDA for violations resulting in massive layoffs - but continued outrageous salaries such as $30 million for 2011 and $145 million retirement fund for CEO Bill Weldon - financially draining US healthcare.
Date Created: 2012, April 4
Keywords: facility, deterioration, fda, violations, recalls, Johnson and Johnson, executive, salaries, layoff
Site accessed 2,847,977 times.
This page accessed 17,008 times.
Bill Weldon's 'restructuring' cut over 10,000 jobs at Johnson & Johnson, reduced equipment maintenance and upgrades and closed doors on what used to be functioning, profitable, facilities. In addition, inaccurate doses from faulty equipment may have led to the death of a child.
It was claimed that the majority of the recalls were for 'musty' smell or odor from due to the preservative used to prolong the life of the wooden shipping pallets in the facilities in Fort Washington and Lancaster Pennsylvania as well as the facility in Las Piedras, Puerto Rico. However, according to FDA documents, "DA, Justice Department take action against McNeil-PPC Inc. Charged with manufacturing and distributing OTC drugs in violation of federal law", the recalls and subsequent plant closures or FDA monitoring of these facilities was due to repeated violations and "failing to comply with current good manufacturing practice requirements as required by federal law." Bill Weldon was not telling the media the truth during press releases associated with the recalls. For example, how many of you are aware that one children's product was recalled for 'metal particles' in the liquid medication? Obviously, this was an equipment issue based on lack of required inspections and routine maintenance - which was not being done.
Now, we move into Doxil, a chemotherapy drug already in short supply since it is made in only one facility. A facility, in Bedford, Ohio, that in the same manner as the other three facilities has been out of FDA manufacturing compliance since at least 2009. The FDA is scrambling to figure out what to do to restore the supply for the 2,700 people on the list who need this drug to stay alive. While the company was Ben Venue, the medications were a Johnson & Johnson product. It was the responsibility of Johnson & Johnson to ensure that Ben Venue was manufacturing their product according to FDA and J&J specifications. In a clean properly maintained facility - that didn't have a bottle of urine in the closet of one of the manufacturing areas. I seriously doubt the person that peed in the bottle washed their hands when they were done relieving themselves before going back to work handling medication. How disgusting is that? Ben Venue voluntarily closed their doors, leaving seriously ill and dying people without the medication they need to be able to stay on cancer treatment plans - and many will likely die without this effective cancer drug. This is a drug used to treat cancer in children who have leukemia - like the little girl that sang the National Anthem at the opening baseball game in 2011.
Shareholders continue to vote for outrageous executive salaries for their buddies at J&J. I agree with Motley Fool that there is definitely Sick Stuff in CEO Pay with regard to Johnson & Johnson's Bill Weldon receiving more than $30 million in pay and benefits and an economy destroying $143.5 million retirement package - while he remains on the board and continues to draw a salary from J&J. Over the last 10 years, in compensation, bonuses and the killer retirement package, Bill Weldon will have received more than $300 MILLION. No wonder we can't afford the products when they aren't part of a recall or unable to be produced because the manufacturing facility was closed from FDA violation.
It seems that William Weldon's 'restructuring' for the benefit of his *ass*tronomical pay, I mean for the benefit of the shareholders included cutting costs everywhere - such as cutting the work force by 10,000 jobs (approximately 8%), cutting back on facility improvements and basic maintenance to the point of risking consumer health, and keeping stock prices flat with a miniscule increase in dividends for shareholders.
However, executive salaries continue to skyrocket - while the company falls apart and cannot meet consumer demands for drugs that are needed to save lives, including the lives of children with leukemia, or meet shareholder expectations.
Through it all, there is the knowledge that the shareholders who own the majority of J&J stock are also business owners and bankers. This makes me smile. See, when shareholders vote to approve outrageous executive pays, the only way to pay the executives, is through The More Jobs You Cut, the Higher Your Pay, cutting jobs and cutting back on maintenance, upgrades and inspections. Weldon was basically allowing the company to fall apart. Less jobs means less money for consumers to spend in the other companies, increased foreclosures and loan defaults screw the bankers back that voted to cut jobs for higher executive salaries. So basically, approving the higher salary for Bill and Friends - cut into your own bottom line ;o)
Supported ONLY by Gifts...
Please note the lack of squiggling, jiggling ads all over the place. I'm not working for advertisers, I'm working for you. Financial support for this work is provided only
by visitors. Only 1 in every 10,000 or so sends help. It would be nice to see that increase. Gifts accepted securely via PayPal - no PayPal account required.
1. Associated Press (2012, January 16). Washington state couple files lawsuit alleging defective Tylenol caused toddler's death. NJ.com. Retrieved from http://www.nj.com/business/index.ssf/2012/01/washington_state_couple_files.html
2. United States Food and Drug Administration (2011, March 10). FDA, Justice Department take action against McNeil-PPC Inc. United States Food and Drug Administration Press Release. Retrieved from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm246685.htm
3. Phil Taylor (2011, November 22). Doxil shortages exacerbated as Ben Venue shutters plant. Pharmafile.com. Retrieved from
4. Peter Loftus (2011, November 30). FDA explores 'all options' to restore Doxil supply. Market Watch. Retrieved from http://www.marketwatch.com/story/fda-explores-all-options-to-restore-doxil-supply-2011-11-30
5. United States Food and Drug Administration (2011, November 30). Ben Venue Laboratories - Voluntary Shutdown. United States Food and Drug Administration Press Release. Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm281782.htm?utm_source=fdaSearch&utm_medium=website&utm_term=ben%20venue&utm_content=5
6. Phil Taylor (2011, November 22). Doxil shortages exacerbated as Ben Venue shutters plant. Pharmafile.com. Retrieved from
7. Alyce Lomax (2012, March 28). Sick stuff in CEO pay. Motley Fool. Retrieved from http://www.fool.com/investing/general/2012/03/28/sick-stuff-in-ceo-pay.aspx
8. Alyce Lomax (). The more jobs you cut, the higher your pay. Motley Fool. Retrieved from http://www.fool.com/investing/general/2010/09/01/the-more-jobs-you-cut-the-higher-your-pay.aspx